Clinical Trials in Huzhou, China
7 recruiting
Showing 1–16 of 16 trials
Recruiting
Phase 3
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
ObesityOverweight
Eli Lilly and Company900 enrolled178 locationsNCT07392190
Recruiting
Real World Clinical Outcomes of Resected ALK-Positive Early Stage NSCLC Patients Treated With Alectinib as Adjuvant Therapy
Carcinoma, Non-Small Cell Lung
Hoffmann-La Roche800 enrolled36 locationsNCT06862869
Recruiting
Phase 3
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Chronic Obstructive Pulmonary Disease
Sanofi942 enrolled150 locationsNCT07190222
Recruiting
Not Applicable
Postoperative Radiotherapy for Early-stage Oral Tongue Squamous Cell Carcinoma Patients With Risk Factors: a Prospective, Multicenter, Randomized Controlled, Open-labelled Trial
Oral Tongue Squamous Cell Carcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University190 enrolled28 locationsNCT07402525
Recruiting
Durvalumab Consolidation After Chemoradiation Therapy for Limited Stage SCLC in China
Limited Stage Small Cell Lung Cancer
AstraZeneca200 enrolled26 locationsNCT07161388
Recruiting
This is a Non-interventional, Study to Assess Demographic Characteristics and Patient Reported Outcomes in China Patients With SEA Treated With Benralizumab
Chronic Obstructive Pulmonary Disease
AstraZeneca1,000 enrolled16 locationsNCT06862206
Recruiting
Phase 2
A Study to Evaluate 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Chronic Obstructive Pulmonary Disease (COPD)
Mabwell (Shanghai) Bioscience Co., Ltd.360 enrolled51 locationsNCT07292714
Recruiting
Phase 3
Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma
Non-Hodgkin's LymphomaHematopoietic Stem Cell Mobilization
The Affiliated People's Hospital of Ningbo University99 enrolled17 locationsNCT06520163
Recruiting
Phase 4
Clinical Study on the Treatment of Stable Bronchiectasis With Bailing Capsules Combined With Guben Kechuan Granules
COPDBronchiectasis
Second Affiliated Hospital, School of Medicine, Zhejiang University214 enrolled5 locationsNCT07114120
Recruiting
Phase 2
Orelabrutinib Combined With Rituximab as First-line Systemic Treatment for Marginal Zone Lymphoma
Marginal Zone Lymphoma (MZL)
Second Affiliated Hospital, School of Medicine, Zhejiang University51 enrolled18 locationsNCT07022223
Recruiting
Phase 4
The Efficacy and Safety of Combining Probiotic VSL#3 With Vedolizumab for the Treatment of Moderate Ulcerative Colitis
Ulcerative Colitis
Second Affiliated Hospital, School of Medicine, Zhejiang University100 enrolled12 locationsNCT06609447
Recruiting
Phase 2
Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma
HER2-positive Gastric CancerAdenocarcinoma of the StomachAdenocarcinoma of Esophagogastric Junction
Yu jiren30 enrolled8 locationsNCT05715931
Recruiting
Phase 3
Comparison Study of EAP and CG Regimens for Mobilizing Hematopoietic Stem Cells in Multiple Myeloma Patients
Multiple MyelomaHematopoietic Stem Cell Mobilization
The Affiliated People's Hospital of Ningbo University99 enrolled16 locationsNCT06520176
Recruiting
Not Applicable
Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm
Lung Adenocarcinoma
Shanghai Pulmonary Hospital, Shanghai, China690 enrolled14 locationsNCT04937283
Recruiting
Not Applicable
Etoposide+Cytarabine+PEG-rhG-CSF as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological Malignancies
Multiple MyelomaLymphoma
The Affiliated People's Hospital of Ningbo University68 enrolled14 locationsNCT05536154
Recruiting
Phase 2
Orelabrutinib Combined With R-CDOP for DLBCL Patients With High-risk of CNS Relapse Defined by CNS-IPI
Diffuse Large B Cell Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang University62 enrolled6 locationsNCT06290817